1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Xu, B. Hua, Q.-X. Nakagawa, S.H. Jia, W. Chu, Y.-C. Katsoyannis, P.G. Weiss, M.A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Protein Sci. PRCIEI 0795 0961-8368 11 104 116 10.1110/ps.ps.32102 11742127 A cavity-forming mutation in insulin induces segmental unfolding of a surrounding alpha-helix. 2002 10.2210/pdb1k3m/pdb pdb_00001k3m 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 2341.618 INSULIN INSULIN A CHAIN (residues 90-110) I2A 1 syn polymer 3410.894 INSULIN INSULIN B CHAIN (residues 25-54) H10D, P28K, K29P 1 syn polymer no no GAVEQCCTSICSLYQLENYCN GAVEQCCTSICSLYQLENYCN A polypeptide(L) no no FVNQHLCGSDLVEALYLVCGERGFFYTKPT FVNQHLCGSDLVEALYLVCGERGFFYTKPT B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2001-10-17 1 1 2008-04-27 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details HELIX DETERMINATION METHOD: AUTHOR RCSB Y RCSB 2001-10-03 REL REL The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human). sample The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human). sample This structure was determined using standard 2D homonuclear techniques. structures with the lowest energy 60 15 2D NOESY DQF-COSY 2D NOESY DQF-COSY 2D NOESY DQF-COSY 7.0 ambient 298 K 7.6 ambient 303 K 1.9 ambient 298 K The structure is based on a total of 416 restraints, 367 are NOE-derived distance constraints, 32 dihedral angle restraints, 17 distance restraints from hydrogen bonds. distance geometry and simulated annealing 1 closest to the average 1.2 mM AlaA2-DKP-Insulin; 100% D2O; 100% D2O 1.2 mM AlaA2-DKP-Insulin; 90% H2O, 10% D2O; 90% H2O/10% D2O 1.2 mM AlaA2-DKP-Insulin; 20% Deuteroacetic Acid, 80% D2O; 20% Deuteroacetic Acid, 80% D2O; Brunger refinement X-PLOR 3.85 Molecular Simulations Inc. refinement DGII InsightII 2000 Varian Inc. processing VNMR 6.1B 600 Varian INOVA GLY 1 n 1 GLY 1 A ALA 2 n 2 ALA 2 A VAL 3 n 3 VAL 3 A GLU 4 n 4 GLU 4 A GLN 5 n 5 GLN 5 A CYS 6 n 6 CYS 6 A CYS 7 n 7 CYS 7 A THR 8 n 8 THR 8 A SER 9 n 9 SER 9 A ILE 10 n 10 ILE 10 A CYS 11 n 11 CYS 11 A SER 12 n 12 SER 12 A LEU 13 n 13 LEU 13 A TYR 14 n 14 TYR 14 A GLN 15 n 15 GLN 15 A LEU 16 n 16 LEU 16 A GLU 17 n 17 GLU 17 A ASN 18 n 18 ASN 18 A TYR 19 n 19 TYR 19 A CYS 20 n 20 CYS 20 A ASN 21 n 21 ASN 21 A PHE 1 n 1 PHE 1 B VAL 2 n 2 VAL 2 B ASN 3 n 3 ASN 3 B GLN 4 n 4 GLN 4 B HIS 5 n 5 HIS 5 B LEU 6 n 6 LEU 6 B CYS 7 n 7 CYS 7 B GLY 8 n 8 GLY 8 B SER 9 n 9 SER 9 B ASP 10 n 10 ASP 10 B LEU 11 n 11 LEU 11 B VAL 12 n 12 VAL 12 B GLU 13 n 13 GLU 13 B ALA 14 n 14 ALA 14 B LEU 15 n 15 LEU 15 B TYR 16 n 16 TYR 16 B LEU 17 n 17 LEU 17 B VAL 18 n 18 VAL 18 B CYS 19 n 19 CYS 19 B GLY 20 n 20 GLY 20 B GLU 21 n 21 GLU 21 B ARG 22 n 22 ARG 22 B GLY 23 n 23 GLY 23 B PHE 24 n 24 PHE 24 B PHE 25 n 25 PHE 25 B TYR 26 n 26 TYR 26 B THR 27 n 27 THR 27 B LYS 28 n 28 LYS 28 B PRO 29 n 29 PRO 29 B THR 30 n 30 THR 30 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 1 B B O H LEU CYS 15 19 1.26 2 B B O H LEU CYS 15 19 1.28 2 B B O H CYS LEU 7 11 1.47 2 A B H O ASN GLY 21 23 1.50 3 B B O H LEU CYS 15 19 1.39 3 B B O H CYS LEU 7 11 1.45 3 A A O HG1 CYS THR 7 8 1.60 4 B B O H CYS LEU 7 11 1.40 4 B B O H LEU CYS 15 19 1.45 4 B B O H ALA VAL 14 18 1.59 5 B B O H LEU CYS 15 19 1.29 5 B B O H CYS LEU 7 11 1.47 6 B B O H LEU CYS 15 19 1.28 7 B B O H LEU CYS 15 19 1.31 7 B B O H SER VAL 9 12 1.56 8 B B O H LEU CYS 15 19 1.49 8 B B O H GLY VAL 8 12 1.58 8 B B O H ALA VAL 14 18 1.59 9 B B O H CYS LEU 7 11 1.42 9 B B O H LEU CYS 15 19 1.46 9 B B O H ALA VAL 14 18 1.52 9 A A O H TYR GLU 14 17 1.58 10 B B O H LEU CYS 15 19 1.52 10 B B O H ALA VAL 14 18 1.52 11 B B O H LEU CYS 15 19 1.32 12 B B O H LEU CYS 15 19 1.27 12 B B O H CYS LEU 7 11 1.43 12 A A O H CYS SER 7 9 1.58 13 B B O H CYS LEU 7 11 1.41 13 B B O H LEU CYS 15 19 1.45 14 B B O H LEU CYS 15 19 1.25 14 B B O H CYS LEU 7 11 1.43 14 A B O H CYS LEU 6 6 1.53 15 B B O H LEU CYS 15 19 1.27 1 B ARG 22 0.192 SIDE CHAIN 2 B ARG 22 0.176 SIDE CHAIN 3 B ARG 22 0.313 SIDE CHAIN 4 B ARG 22 0.308 SIDE CHAIN 5 B ARG 22 0.275 SIDE CHAIN 6 B ARG 22 0.284 SIDE CHAIN 7 B ARG 22 0.216 SIDE CHAIN 8 B ARG 22 0.270 SIDE CHAIN 9 B ARG 22 0.253 SIDE CHAIN 10 B ARG 22 0.224 SIDE CHAIN 11 B ARG 22 0.188 SIDE CHAIN 12 B ARG 22 0.264 SIDE CHAIN 13 B ARG 22 0.250 SIDE CHAIN 14 B ARG 22 0.282 SIDE CHAIN 15 B ARG 22 0.316 SIDE CHAIN 1 A VAL 3 -122.64 -69.27 1 A GLN 5 -163.14 60.57 1 A CYS 6 160.00 -32.48 1 A SER 9 164.97 -139.82 1 A CYS 11 -78.77 -138.40 1 A LEU 13 -37.36 -29.85 1 A CYS 20 -74.41 -162.35 1 B ASN 3 -177.35 138.16 1 B HIS 5 65.90 120.89 2 A VAL 3 -161.83 -62.85 2 A SER 9 167.76 170.82 2 A CYS 11 -73.65 -124.75 2 A LEU 13 -32.74 -36.25 2 B TYR 26 -86.60 49.92 2 B LYS 28 55.38 78.52 3 A ALA 2 -69.15 89.89 3 A VAL 3 -133.65 -62.07 3 A SER 9 163.23 -179.93 3 A CYS 11 -59.25 -112.63 3 A LEU 13 -35.90 -31.23 3 A CYS 20 -104.60 -165.61 3 B ASN 3 -159.24 54.19 3 B GLN 4 -160.49 98.26 3 B HIS 5 55.12 114.62 3 B SER 9 -51.15 -71.94 3 B GLU 21 81.72 -56.35 3 B ARG 22 -54.13 176.65 4 A ALA 2 -108.22 72.23 4 A VAL 3 -167.56 -56.33 4 A GLU 4 -60.30 -139.75 4 A GLN 5 76.29 -76.30 4 A SER 9 159.57 179.36 4 A CYS 11 -61.36 -117.58 4 A LEU 13 -35.25 -32.03 4 A CYS 20 -129.46 -166.12 4 B ASN 3 -112.16 58.56 4 B GLN 4 -146.42 -72.33 4 B ARG 22 -109.07 -100.68 4 B LYS 28 -174.04 57.07 5 A ALA 2 52.13 84.27 5 A VAL 3 -95.67 -146.95 5 A GLU 4 81.59 6.56 5 A SER 9 164.35 -138.11 5 A CYS 11 -53.15 -174.05 5 A LEU 13 -29.75 -47.17 5 A CYS 20 -126.74 -165.62 5 B VAL 2 -139.58 -149.80 5 B ASN 3 171.50 -172.62 5 B GLN 4 -127.43 -141.48 6 A ALA 2 72.99 87.52 6 A VAL 3 -144.01 -41.27 6 A GLN 5 -152.23 15.69 6 A THR 8 -92.60 37.56 6 A SER 9 158.41 -158.92 6 A CYS 11 -62.32 -144.35 6 A LEU 13 -35.27 -32.02 6 A CYS 20 -126.80 -165.36 6 B ASN 3 84.59 160.31 6 B GLU 21 -149.11 19.87 6 B TYR 26 -168.60 68.36 6 B LYS 28 64.91 85.62 7 A VAL 3 170.45 -92.18 7 A GLU 4 -69.78 -150.94 7 A GLN 5 78.30 37.98 7 A CYS 6 -161.26 -52.05 7 A THR 8 41.83 29.71 7 A SER 9 171.58 -155.72 7 A CYS 11 -69.57 -116.00 7 B GLN 4 -120.28 -168.22 7 B SER 9 -55.23 -77.91 7 B GLU 21 85.09 -40.22 7 B LYS 28 53.74 73.80 8 A GLU 4 38.38 40.12 8 A CYS 6 -153.83 17.63 8 A SER 9 154.58 118.54 8 A CYS 11 -60.00 -94.43 8 A SER 12 -161.66 107.03 8 A LEU 13 -34.92 -32.03 8 B ASN 3 -115.65 -166.72 8 B HIS 5 78.63 54.04 8 B ARG 22 -72.58 -165.61 8 B TYR 26 53.65 -77.37 8 B THR 27 -95.37 -146.83 9 A VAL 3 65.66 -71.99 9 A GLN 5 -140.53 11.43 9 A CYS 6 -159.75 -51.58 9 A CYS 7 -51.48 -175.85 9 A SER 9 160.66 -165.58 9 A CYS 11 -63.19 -113.94 9 A CYS 20 -102.31 -165.45 9 B THR 27 -155.10 28.42 10 A ALA 2 66.75 113.77 10 A SER 9 159.10 145.48 10 A CYS 11 -88.36 -120.53 10 A LEU 13 -36.35 -32.58 10 B VAL 2 -85.49 -153.99 10 B ASN 3 -166.26 64.86 10 B GLN 4 -120.13 -164.60 10 B CYS 19 -82.94 46.13 10 B GLU 21 79.34 -69.18 10 B ARG 22 -4.79 -86.45 11 A ALA 2 50.77 70.22 11 A GLU 4 -62.28 85.94 11 A GLN 5 -148.98 -39.27 11 A THR 8 48.20 27.31 11 A SER 9 164.61 172.64 11 A CYS 11 -64.23 -117.58 11 A LEU 13 -36.97 -31.15 11 A CYS 20 -102.20 -167.74 11 B SER 9 -51.96 -71.31 11 B THR 27 -116.32 -165.22 12 A ALA 2 163.30 -44.10 12 A CYS 7 -65.37 -93.34 12 A THR 8 -69.86 61.10 12 A SER 9 164.05 148.65 12 A CYS 11 -53.17 -100.37 12 A LEU 13 -39.35 -28.24 12 B GLN 4 -98.35 -144.46 12 B HIS 5 -44.65 158.33 12 B SER 9 -44.96 -71.09 13 A ALA 2 73.16 40.91 13 A SER 9 160.81 151.72 13 A CYS 11 -63.64 -127.38 13 A LEU 13 -36.74 -30.65 13 B GLN 4 -122.17 -103.33 13 B CYS 19 -70.46 49.13 13 B THR 27 -147.08 -106.84 13 B LYS 28 40.42 85.08 14 A VAL 3 -154.69 -47.67 14 A GLU 4 -106.92 58.65 14 A SER 9 165.64 -139.42 14 A CYS 11 -69.30 -112.17 14 A SER 12 -160.99 118.69 14 A CYS 20 -76.77 -161.74 14 B VAL 2 -141.36 -153.10 14 B ASN 3 -177.90 76.72 14 B GLN 4 -143.62 -157.21 14 B SER 9 -48.82 -70.75 14 B CYS 19 -74.95 45.40 14 B GLU 21 161.94 -23.75 14 B TYR 26 -102.48 -163.55 14 B THR 27 -79.42 -117.25 15 A VAL 3 -163.68 -73.05 15 A GLU 4 -54.58 103.04 15 A GLN 5 160.70 -28.06 15 A SER 9 173.14 -142.50 15 A CYS 11 -61.79 -112.62 15 A SER 12 -160.98 113.06 15 B ASN 3 -148.61 47.78 15 B GLN 4 -134.40 -51.73 15 B GLU 21 83.87 -36.26 15 B PHE 25 -99.27 50.77 15 B TYR 26 -176.47 32.78 NMR STRUCTURE OF HUMAN INSULIN MUTANT ILE-A2-ALA, HIS-B10-ASP, PRO-B28-LYS, LYS-B29-PRO, 15 STRUCTURES 1 N N 2 N N A LEU 13 A LEU 13 HELX_P A TYR 19 A TYR 19 1 1 7 B SER 9 B SER 9 HELX_P B CYS 19 B CYS 19 1 2 11 disulf 2.021 A CYS 6 A SG CYS 6 1_555 A CYS 11 A SG CYS 11 1_555 disulf 2.019 A CYS 7 A SG CYS 7 1_555 B CYS 7 B SG CYS 7 1_555 disulf 2.019 A CYS 20 A SG CYS 20 1_555 B CYS 19 B SG CYS 19 1_555 HORMONE/GROWTH FACTOR HORMONE, HUMAN INSULIN, MUTANT, HORMONE-GROWTH FACTOR COMPLEX INS_HUMAN UNP 1 90 P01308 GIVEQCCTSICSLYQLENYCN INS_HUMAN UNP 2 25 P01308 FVNQHLCGSHLVEALYLVCGERGFFYTPKT 90 110 1K3M 1 21 P01308 A 1 1 21 25 54 1K3M 1 30 P01308 B 2 1 30 1 ILE engineered mutation ALA 2 1K3M A P01308 UNP 91 2 2 HIS engineered mutation ASP 10 1K3M B P01308 UNP 34 10 2 PRO engineered mutation LYS 28 1K3M B P01308 UNP 52 28 2 LYS engineered mutation PRO 29 1K3M B P01308 UNP 53 29